NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

AURO LABORATORIES LTD. (BSE: 530233)

 
530233 Technical Analysis
5
As on 24th Dec 2024 530233 SHARE Price closed @ 276.75 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 150.45 & Strong Buy for SHORT-TERM with Stoploss of 217.31 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

530233SHARE Price

Open 290.00 Change Price %
High 290.00 1 Day 6.00 2.22
Low 271.10 1 Week 81.95 42.07
Close 276.75 1 Month 81.95 42.07
Volume 5390 1 Year 164.25 146.00
52 Week High 307.20 | 52 Week Low 118.10
 
BSE INDIA Most Active Stocks
532822 7.47 -0.13%
532411 0.41 0.00%
517001 0.09 12.50%
511700 1.01 -0.98%
512149 0.88 0.00%
511389 7.25 -2.42%
534690 7.65 4.79%
532775 2.04 -0.97%
531328 1.05 0.96%
532648 19.80 -0.60%
 
BSE INDIA Top Gainers Stocks
519200 3.05 281.25%
512063 18.00 200.00%
530905 50.00 194.12%
513630 1.77 86.32%
512559 48.48 20.00%
530883 23.40 20.00%
521234 44.24 19.99%
590074 7.73 15.72%
507864 85.03 14.46%
526544 7.53 14.09%
 
BSE INDIA Top Losers Stocks
513012 0.68 -87.17%
504387 25.70 -76.38%
505658 2.99 -73.93%
509910 22.68 -68.32%
507543 2.58 -30.46%
533102 222.15 -19.99%
506113 134.40 -19.95%
533004 3.35 -18.29%
531838 0.05 -16.67%
533498 90.00 -15.61%
 
 
530233
Daily Charts
530233
Intraday Charts
Whats New @
Bazaartrend
530233
Free Analysis
 
530233 Important Levels Intraday
RESISTANCE313.17
RESISTANCE301.49
RESISTANCE294.27
RESISTANCE287.05
SUPPORT266.45
SUPPORT259.23
SUPPORT252.01
SUPPORT240.33
 
530233 Target May 2025
4th UP Target0
3rd UP Target0
2nd UP Target0
1st UP Target0
1st DOWN Target0
2nd DOWN Target0
3rd DOWN Target0
4th DOWN Target0
 
530233 Weekly Target
4th UP Target0.00
3rd UP Target0.00
2nd UP Target0.00
1st UP Target0.00
1st DOWN Target0.00
2nd DOWN Target0.00
3rd DOWN Target0.00
4th DOWN Target0.00
 
530233 Target2025
4th UP Target318.63
3rd UP Target257.91
2nd UP Target220.38
1st UP Target182.85
1st DOWN Target75.75
2nd DOWN Target38.22
3rd DOWN Target0.69
4th DOWN Target-60.03
 
 
530233 Other Details
Segment EQ
Market Capital 530697376.00
Sector Other
Industry Other
Offical website >
 
530233 Address
530233
 
530233 Latest News
 
Your Comments and Response on AURO LABORATORIES LTD.
 
530233 Business Profile
Auro Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs), intermediates, and generic formulations in India. It offers APIs for various drugs, such as antihistamine, muscle relaxant, diuretic, iron deficiency, anti-diabetic, anti-fungal, anti-ulcer, iodine supplement, anti-malaria, analgesics, antacids, and anti-inflammatory, as well as for other products, including potassium iodide, sodium iodide, and microcrystalline cellulose. The company also provides specialty chemicals comprising guanidine nitrate; dimethyl amine HCl; 2-ethoxy benzoic acid; and trimethoxy benzoic acid. In addition, it offers intermediates consisting of glibenclamde sulphonamide for use in API glibenclamide; cis-bramo benzoate and cls-tosylate that are used in API Ketoconazol; trimethoxy benzoic acid; 2-ethoxy benzoic acid for use in API sildenafil citrate; and 5-bromo phthalide that is used in API citalopram. It also exports products to Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain, and the United Kingdom. Auro Laboratories Limited was incorporated in 1989 and is based in Mumbai, India. Address: 314, T.V. Industrial Estate, Mumbai, India, 400030
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service